// App-Quantinova.ai

e18114 : Relationship of anaplastic thyroid cancer high tumor mutation burden and MSI-H status with response to anti-PD1 monotherapy.

Researchers

Presenter

  • Saad A. Khan

Principal Investigators

  • Pamela Kurian

  • Bianca Mobley

  • Tam Burks

  • Muhammad Shaalan Beg

  • Jeffrey S. Ross

  • Siraj Mahamed Ali

  • Daniel W. Bowles

Medical Centers

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • UTSouthwestern Medical Center, Dallas, TX

  • Upstate Medical University, Syracuse, NY

  • Foundation Medicine, Inc, Cambridge, MA

  • University of Colorado Cancer Center, Aurora, CO

Locations

  • United States

Companies

  • Foundation Medicine,

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Microsatellite instability-high

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved